Cytoxicity of 1-alkylperhydroazepine N-oxides and quantitative structure-activity relationships

International Journal of Biochemistry and Cell Biology

Volumn 30, Issue 11, 1998, Pages 1253-1264

  Miko, Milan ^a   Devinsky, Ferdinand ^b  

^a SLOVAK UNIVERSITY OF TECHNOLOGY   (Slovakia)

^b Faculty of Natural Sciences   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ALKYL GROUP; AMINE OXIDE; CARBON; CARBON 14; THYMIDINE; URIDINE; VALINE;

ANIMAL CELL; ARTICLE; CYTOTOXICITY; EHRLICH ASCITES TUMOR CELL; MOUSE; NONHUMAN; STRUCTURE ACTIVITY RELATION;

ADENINE; ANIMALS; AZEPINES; CARCINOMA, EHRLICH TUMOR; CYCLIC N-OXIDES; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; MICE; PROTEIN BIOSYNTHESIS; STRUCTURE-ACTIVITY RELATIONSHIP; VALINE;

EID: 0032213810     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(98)00070-3     Document Type: Article

References (49)

1. [1] E.P. Linton, The dipole moments of amine oxides, J. Amer. Chem. Soc. 62 (1940) 1945-1948.
2. [2] C.C.J. Culvenor, Amine oxides. Rev. Pure Appl. Chem. 3 (1953) 83-114.
3. [3] K. Lindner, Surface-active amine oxides, Ten side I (1964) 112-115.
4. [4] E. Ochiai, Aromatic amine oxides, Elsevier Publishing, Amsterdam, 1967.
5. [5] M.H. Bickel, The pharmacology and biochemistry of N-oxides, Pharmacol. Rev. 21 (1969) 325-355.
6. [6] P. Hlavica, Biological oxidation of nitrogen in organic compounds and disposition of N-oxized products. Crit. Rev. Biochem. 12 (1982) 39-101.
7. [7] F. Dcvinsky, Amine oxides. XI. Non-aromatic amine oxides: biological effects, Acta Fac. Pharm. Universitatis Comenianae 39 (1985) 197-215.
8. [8] F. Devinsky, Amine oxides. X. Non-aromatic amine oxides: physico-chemical properties and some characteristic reactions, Acta Fac. Pharm. Universitatis Comenianae 39 (1985) 173-196.
9. [9] F. Devinsky, Amine oxides. XVlI, Non-aromatic amine oxides. Their use in organic synthesis and industry, Acta Fac. Pharm. Universitatis Comenianae 40 (1986) 63-83.
10. [10] M. Ferencik, I. Lacko, F. Devinsky, Immunomodulatory activity of some amphiphilic compounds, Pharmazie 45 (1990) 695-496.
11. [11] R.B. Ashman, B.W. Ninham, Immunosuppressive effects of catiomc vesicles, Mol. Immunol. 22 (1985) 609-612.
12. [12] R.B. Ashman, R.V. Blanden, Interaction of amphiphilic aggregates with cells of the immune system. Immunol. Today 7 (1986) 278-283.
13. [13] H Kubinyi, Lipophilicity and biological activity: the use of the bilinear model in QSAR, in: M. Kuchar (Ed.), QSAR in Design of Bioactive Compounds, Prous Int. Pub., Barcelona, 1984. pp. 321-346.
14. [14] F. Devinsky, I. Lacko, D. Mlynarcik, E. Svajdlenka, V. Borovska, Quaternary ammonium salts. XXXIII. QSAR of antimicrobially active niketamide derivatives, Chem. Pap. 44(1990) 159-170.
15. [15] F. Devinsky, I. Lacko, D. Mlynarcik, Aggregation properties as a measure of lipophilicity, in: QSAR Studies of Antimicrobially active Amphiphiles, in: M. Kuchar, V. Rejholcc (Eds.). QSAR in Design of Bioactive Compounds, chap. 3 Practical Aplications of QSAR Approaches. Prous Int. Pub., Barcelona, 1992. pp. 233-247.
16. [16] F. Devinsky, I. Lacko, D Mlynarcik, E. Svajdlenka, L. Masarova, QSAR of monoquaternary surface active antimicrobials: the parabolic and the bilinear case, Acta Fac. Pharm. Universitatis Comenianae 44 (1990) 127-144.
17. [17] J.A. Scgura, M.A. Medina. F.J. Alonso. F. Sanches-Jimenez, I. Nunez de Castro, Glycolysis and glulaminolysis in perfused Ehrlich ascites tumor cells. Cell Biochem. Fund. 7 (1989) 7-10.
18. [18] M.A. Medina, F. Sanchez-Jimenez, I. Nunez de Castro, Subcellular distribution of adenine nucleotides in two Ehrlich cell lines metabolizing glucose. Biol. Chem. Hoppe-Seyler 371 (1990) 625-629.
19. [19] M. Miko, L. Drobnica, Effects of antibiotics nogalamycin. cirolemycin and tubercidin on endogenous respiration of tumor cells and oxidative phosphorylation of mammalian mitochondria, Experientia 31 (1975) 832-835.
20. [20] M. Miko, B. Chance, Ethidium bromide as an uncoupler of oxidative phosphorylation, FEBS Lett. 54 (1975) 347-352.
21. [21] M. Miko, B. Chance, Isothiocyanates. A new class of uncouplers, Biochim. Biophys. Acta 396 (1975) 165-174.
22. [22] M. Gosalvez, M. Blanco, J. Hunter, M. Miko, B. Chance, Effects of anticancer agents on the respiration of isolated mitochondria and tumor cells, Eur. J. Cancer 10 (1975) 567-574.
23. [23] M. Miko, L. Drobnica, Metabolic activity of the Ehrlich ascites carcinoma cells and significance of ascites scrum addition, Neoplasma 16 (1969) 161-169.
24. [24] M. Miko, L. Drobnica, Metabolic activity of the Ehrlich ascites cells in synthetic media and the significance of ascites serum addition. Neoplasma 19 (1972) 163-173.
25. [25] B. Chance, B. Hess, Metabolic control mechanism. 1. Electron transfer in the mammalian cells, J. Biol. Chem. 234 (1959) 2404-2412.
26. [26] M. Miko, L. Drobnica, Rapid in vitro technique of primary screening for anticancer substances, in: Abstracts of Twelfth International Cancer Congress, vol. 1, Buenos Aires, Argentina, 1978. pp. 287-288.
27. [27] M. Miko, L. Drobnica, B. Chance, Inhibition of energy metabolism in Ehrlich ascites cells treated with dactylarin in vitro, Cancer Res. 39 (1979) 4242-4251.
28. [28] M. Miko, J. Krepelka, M. Melka, Primary screening and inhibition of macromolecular biosynthesis in Ehrlich ascites cells by benzo(c)fluorene derivatives. Drug Metab. Drug Interact. 9 (1991) 1-22.
29. [29] M. Miko, L. Drobnica, A. Jindra et al. Effect of chloroand bromo-derivatives of isocrotonic acid on bioenergetic processes in Ehrlich ascites cells and isolated mitochondria, Neoplasma 26 (1979) 449-460.
30. [30] M. Miko, F. Devinsky, In vitro cytotoxic activity of 1-alkylpiperidine N-oxides and quantitative structure-activity relationships, Anticancer Drugs 4 (1993) 471-478.
31. [31] M. Miko, F. Devinsky, Relationships between the chemical structure and cytotoxicity of 4-alkylmorpholine N-oxides, Drug Metab. Drug Interact. 9 (1991) 333-351.
32. [32] F. Devinsky, I. Lacko, D. Mlynarcik, V. Racansky, L. Krasnec, Relationship between critical micelle concentrations and minimum inhibitory concentrations for some nonaromatic quaternary ammonium salts and amine oxides, Tenside Detergents 22 (1985) 10-15.
33. [33] G.E. Demtrakopoulos, B. Linn, H. Amos, Rapid loss of ATP by tumor cells deprived of glucose: contrast to normal cells, Biocbem. Biophys. Res. Commun. 82 (1978) 787-792.
34. [34] S.B. Sobotka, M.R. Berger, Underestimation of the antiproliferative efficacy of certain groups of antineoplastic agents by the MTT-assay, in: D. Adam, T. Buchner, E. Rubinstein (Eds.), Recent Advances in Chemotherapy; Anticancer Section, Futuramed Publishers, Munich, 1992, pp. 2588-2589.
35. [35] J. Subik, G. Takacsova, M. Psenak, F. Devinsky, Antimicrobial activity of amine oxides: mode of action and structure-activity correlation. Antimicrob. Agents Chemother. 12 (1977) 139-146.
36. [36] F. Devinsky, I. Lacko, D. Mlynarcik, L. Krasnec, Amine oxides VIII. Preparation, infrared spectra, and antimicrobial activity of some N-oxides of N,N-dialkylaminoalkyl esters and N′,N′-dimethylaminoalkylamides of dodecanoic acid, Chem. Zvesti 37 (1983) 263-271.
37. [37] M. Volm, Use of tritiated nucleoside incorporation for prediction of sensitivity of tumors to cytostatic agents. Behring Inst. Mitt. 74 (1984) 273-284.
38. [38] D.D. Von Hoff, B. Forseth, L.E. Warfei, Use of a radiometric system to screen for antineoplastic agents: correlation with a human tumor cloning system. Cancer Res. 45 (1985) 4032-4038.
39. [39] W. Scheithauer, G.M. Clark. M.P. Moyer, D.D. Von Hoff, New screening system for selection of anticancer drugs for treatment of human colorectal cancer, Cancer Res. 46 (1986) 2703-2709.
40. [40] B.T. Hill, The effectiveness of clinically useful antitumor agents as inhibitors of RNA polymerases, Cancer Biochem. Biophys. 2 (1977) 43-50.
41. [41] F. Farber, ATP and cell integrity, Fed. Proc. 32 (1973) 1534-1538.
42. [42] S.S. Daoud, Cell membranes as targets for anticancer drug action, Anticancer Drugs 3 (1992) 443-453.
43. [43] L.J. Mandel, Bioenergetics of membrane transport processes, in: T. Andreoli (Ed.), Physiology of Membrane Disorders, Plenum Medical, New York, 1986, pp. 221 231.
44. [44] F. Sersen, A. Leitmanova, F. Devmsky, I. Lacko, P. Balgavy, A spin label study of perturbation effects of N-(methyldodecyl)-N,N,N,-trirnethylammonium bromide and N-(1-methyldodecyl)-N,N-dimethylamine oxide on model membranes prepared from Escherichia coli-isolated lipids, Gen. Physiol. Biophys. 8 (1989) 133-156.
45. [45] A. Kopecka-Leitmanova, F. Devinsky, D. Mlynarcik, I. Lacko, Interaction of amine oxides and quaternary ammonium salts with membrane and membrane-associated processes in E. coli cells: mode of action, Drug Metab. Drug Interact. 7 (1989) 29-51.
46. [46] F. Devinsky, A. Leitmanova-Kopecka, F. Sersen, P. Balgavy, Cut-off effect in antimicrobial activity and in membrane perturbation efficiency of the homologous series of N,N-dimethylalkylamine oxides, J. Pharm. Pharmacol. 42 (1990) 790-794.
47. [47] C.P. Burns, Membranes and cancer chemotherapy, Cancer Invest. 6 (1988) 439-451.
48. [48] S.J. Friedman, P. Skehan, Cell membranes: targets for selective antitumor chemotherapy, in: I.L. Cameron(Ed.), Novel Approach to Cancer Chemotherapy, Academic Press. Orlando, 1984, pp. 329-354.
49. [49] J.A. Hickman, Membrane targets in cancer chemotherapy, Eur. J. Clin. Oncol. 24 (1988) 1385-1390.